Repotrectinib Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of repotrectinib that may be used in the treatment of breast, colorectal, endometrial, esophageal and esophagogastric junction, gastric, hepatobiliary, occult primary, ovarian, fallopian tube, primary peritoneal, vaginal, vulvar, and non-small cell lung cancer (NSCLC), ampullary, appendiceal, small bowel and pancreastic adenocarcinoma, gastrointestinal stromal tumor, salivary gland tumor, extrapulmonary poorly differentiated, neuroendocrine carcinoma/large or small cell carcinoma/mixed neuroendocrine-non-neuroendocrine neoplasms and histiocytic neoplasms, soft tissue sarcoma, uterine sarcoma, anaplastic, papillary, follicular and oncocytic carcinoma.

**Synonyms:** - Augtyro Regimen